Home Associations of County-level Radiologist and Mammography Facility Supply with Screening Mammography Rates in the United States
Post
Cancel

Associations of County-level Radiologist and Mammography Facility Supply with Screening Mammography Rates in the United States

Rationale and Objectives

The present study aims to assess associations of Medicare beneficiary screening mammography rates with local mammography facility and radiologist availability.

Materials and Methods

Mammography screening rates for Medicare fee-for-service beneficiaries were obtained for US counties using the County Health Rankings data set. County-level certified mammography facility counts were obtained from the United States Food and Drug Administration. County-level mammogram-interpreting radiologist and breast imaging subspecialist counts were determined using Centers for Medicare & Medicaid Services fee-for-service claims files. Spearman correlations and multivariable linear regressions were performed using counties’ facility and radiologist counts, as well as counts normalized to counties’ Medicare fee-for-service beneficiary volume and land area.

Results

Across 3035 included counties, average screening mammography rates were 60.5% ± 8.2% (range 26%–88%). Correlations between county-level screening rates and total mammography facilities, facilities per 100,000 square mile county area, total mammography-interpreting radiologists, and mammography-interpreting radiologists per 100,000 county-level Medicare beneficiaries were all weak (r = 0.22–0.26). Correlations between county-level screening rates and mammography rates per 100,000 Medicare beneficiaries, total breast imaging subspecialist radiologists, and breast imaging subspecialist radiologists per 100,000 Medicare beneficiaries were all minimal (r = 0.06–0.16). Multivariable analyses overall demonstrated radiologist supply to have a stronger independent effect than facility supply, although effect sizes remained weak for both.

Conclusion

Mammography facility and radiologist supply-side factors are only weakly associated with county-level Medicare beneficiary screening mammography rates, and as such, screening mammography may differ from many other health-care services. Although efforts to enhance facility and radiologist supply may be helpful, initiatives to improve screening mammography rates should focus more on demand-side factors, such as patient education and primary care physician education and access.

Introduction

Screening mammography rates are highly variable among populations . In particular, previous investigations have focused on the impact of a wide variety of patient characteristics on screening rates, such as demographic, behavioral, and psychosocial factors . Screening mammography rates are also influenced by characteristics of patients’ insurance and of the physicians who order mammograms and counsel women regarding undergoing screening . Awareness of factors that may drive changes in screening rates may thus be important for designing targeted interventions and optimizing efforts at improving screening compliance.

For other radiology services, supply-side factors (eg, the availability of scanners and physicians) have been associated with variation in utilization . Although screening mammography rates are clearly heavily influenced by a range of demand-side factors (eg, those related to patients and referring physicians as drivers of utilization), it is also possible that screening rates are also influenced by supply-side factors relating to the resources and infrastructure required to offer screening services . Namely, the local supply of both mammography facilities and radiologists performing mammography may impact the ease of obtaining and thus demand for a mammogram and consequently impact screening rates. However, the relationship of supply-side factors and screening rates is not firmly established. Past studies have commonly explored supply-side factors in limited geographic regions or outside of the United States , and far more heavily focused on facility supply with minimal attention to the supply of radiologists offering mammography screening services . Most importantly, earlier studies have yielded inconsistent results regarding any potential relationships , and the topic has received little attention in recent years despite considerable interval changes in facility availability, radiologist practice patterns, and screening guidelines themselves (eg, the conversion from analog to digital mammography; the introduction of digital breast tomosynthesis; changing guidelines from the United States Preventive Services Task Force , as well as from the American Cancer Society and the American College of Radiology ). Therefore, to better understand the role of supply-side factors in impacting screening mammography, the aim of this study was to assess, at the US county level, the association between Medicare beneficiary screening mammography rates and the local availability of mammography facilities and mammography-interpreting radiologists.

Methods

Get Radiology Tree app to read full this article<

Get Radiology Tree app to read full this article<

Get Radiology Tree app to read full this article<

Get Radiology Tree app to read full this article<

Get Radiology Tree app to read full this article<

Get Radiology Tree app to read full this article<

Results

Get Radiology Tree app to read full this article<

Get Radiology Tree app to read full this article<

TABLE 1

Summary of County-level Characteristics Among 3035 Included Counties

Measure Mean ± SD Range Mammography screening rate (%) 60.5 ± 8.2 26–88 Total mammography facilities 2.81 ± 7.30 0–203 Mammography facilities per 100,000 Medicare FFS beneficiaries 31.4 ± 45.8 0–719 Mammography facilities per 100,000 square miles 673.1 ± 5,543.0 0–271,588 Total mammography-performing radiologists 4.2 ± 13.4 0–252 Mammography-performing radiologists per 100,000 Medicare FFS beneficiaries 22.1 ± 59.0 0–1,185 Total breast imaging subspecialist radiologists 0.9 ± 4.6 0–108 Breast imaging subspecialist radiologists per 100,000 Medicare FFS beneficiaries 3.4 ± 40.1 0–2,083

FFS, fee-for-service; SD, standard deviation.

Get Radiology Tree app to read full this article<

Get Radiology Tree app to read full this article<

TABLE 2

Correlation of County-level Characteristics with Mammography Screening Rates

Measure r_P_ Total mammography facilities +0.24<.001 Mammography facilities per 100,000 Medicare FFS beneficiaries +0.06<.001 Mammography facilities per 100,000 square miles +0.26<.001 Total mammography-performing radiologists +0.24<.001 Mammography-performing radiologists per 100,000 Medicare FFS beneficiaries +0.22<.001 Total breast imaging subspecialist radiologists +0.16<.001 Breast imaging subspecialist radiologists per 100,000 Medicare FFS beneficiaries +0.16<.001

FFS, fee-for-service.

P -values listed in bold when statistically significant at P < 0.001.

Get Radiology Tree app to read full this article<

Get Radiology Tree app to read full this article<

TABLE 3

Results of Series of Multivariable Regression Models Exploring Associations Between Screening Mammography Rates and Combinations of County-level Measures of Mammography Facilities and Mammography-performing Radiologists

Models Measure β_P_ 1 Total mammography facilities −0.02 .633 Total mammography-performing radiologists +0.08<.001 2 Total mammography facilities +0.18<.001 Total breast imaging subspecialist radiologists −0.13 .015 3 Mammography facilities per 100,000 Medicare FFS beneficiaries −0.007 .045 Mammography-performing radiologists per 100,000 Medicare FFS beneficiaries +0.01<.001 4 Mammography facilities per 100,000 Medicare FFS beneficiaries −0.0008 .791 Breast imaging subspecialist radiologists per 100,000 Medicare FFS beneficiaries +0.007 .047 5 Mammography facilities per 100,000 square miles 0.00003 .309 Mammography-performing radiologists per 100,000 Medicare FFS beneficiaries +0.01<.001 6 Mammography facilities per 100,000 square miles 0.00003 .194 Breast imaging subspecialist radiologists per 100,000 Medicare FFS beneficiaries 0.007 .054

FFS, fee-for-service.

P -values listed in bold when statistically significant at P < 0.001.

Get Radiology Tree app to read full this article<

Discussion

Get Radiology Tree app to read full this article<

Get Radiology Tree app to read full this article<

Get Radiology Tree app to read full this article<

Get Radiology Tree app to read full this article<

Get Radiology Tree app to read full this article<

Get Radiology Tree app to read full this article<

Get Radiology Tree app to read full this article<

References

  • 1. Center for Disease Control and Prevention, National Center for Health Statistics : Health, United States, 2016: with chartbook on long-term trends in health. Hyattsville, MD2017. Available at: https://www.cdc.gov/nchs/data/hus/hus16.pdf#070

  • 2. Gierisch J.M., Earp J.A., Brewer N.T., et. al.: Longitudinal predictors of nonadherence to maintenance of mammography. Cancer Epidemiol Biomarkers Prev 2010; 19: pp. 1103-1111.

  • 3. DeSantis C.E., Fedewa S.A., Goding Sauer A., et. al.: Breast cancer statistics, 2015: convergence of incidence rates between black and white women. CA Cancer J Clin 2016; 66: pp. 31-42.

  • 4. Aro A.R., de Koning H.J., Absetz P., et. al.: Psychosocial predictors of first attendance for organised mammography screening. J Med Screen 1999; 6: pp. 82-88.

  • 5. Narayan A., Fischer A., Zhang Z., et. al.: Nationwide cross-sectional adherence to mammography screening guidelines: national behavioral risk factor surveillance system survey results. Breast Cancer Res Treat 2017; 164: pp. 719-725.

  • 6. Hung A., Stuart B., Harris I.: The effect of Medicare Advantage enrollment on mammographic screening. Am J Manag Care 2016; 22: pp. e53-e59.

  • 7. Rosenkrantz A.B., Fleming M., Duszak R.: Variation in screening mammography rates among Medicare advantage plans. J Am Coll Radiol 2017; 14: pp. 1013-1019.

  • 8. Weingarten S.R., Stone E., Green A., et. al.: A study of patient satisfaction and adherence to preventive care practice guidelines. Am J Med 1995; 99: pp. 590-596.

  • 9. Peipins L.A., Shapiro J.A., Bobo J.K., et. al.: Impact of women’s experiences during mammography on adherence to rescreening (United States). Cancer Causes Control 2006; 17: pp. 439-447.

  • 10. Sheppard V.B., Wang J., Yi B., et. al.: Are health-care relationships important for mammography adherence in Latinas?. J Gen Intern Med 2008; 23: pp. 2024-2030.

  • 11. Haggstrom D.A., Phillips K.A., Liang S.Y., et. al.: Variation in screening mammography and Papanicolaou smear by primary care physician specialty and gatekeeper plan (United States). Cancer Causes Control 2004; 15: pp. 883-892.

  • 12. Kung P.T., Tsai W.C., Yaung C.L., et. al.: Determinants of computed tomography and magnetic resonance imaging utilization in Taiwan. Int J Technol Assess Health Care 2005; 21: pp. 81-88.

  • 13. Elkin E.B., Ishill N.M., Snow J.G., et. al.: Geographic access and the use of screening mammography. Med Care 2010; 48: pp. 349-356.

  • 14. Engelman K.K., Hawley D.B., Gazaway R., et. al.: Impact of geographic barriers on the utilization of mammograms by older rural women. J Am Geriatr Soc 2002; 50: pp. 62-68.

  • 15. Elting L.S., Cooksley C.D., Bekele B.N., et. al.: Mammography capacity impact on screening rates and breast cancer stage at diagnosis. Am J Prev Med 2009; 37: pp. 102-108.

  • 16. Onega T., Cook A., Kirlin B., et. al.: The influence of travel time on breast cancer characteristics, receipt of primary therapy, and surveillance mammography. Breast Cancer Res Treat 2011; 129: pp. 269-275.

  • 17. Sano H., Goto R., Hamashima C.: Does lack of resources impair access to breast and cervical cancer screening in Japan?. PLoS ONE 2017; 12: pp. e0180819.

  • 18. St-Jacques S., Philibert M.D., Langlois A., et. al.: Geographic access to mammography screening centre and participation of women in the Quebec Breast Cancer Screening Programme. J Epidemiol Community Health 2013; 67: pp. 861-867.

  • 19. Nelson H.D., Tyne K., Naik A., et. al.: Screening for breast cancer: systematic evidence review update for the US Preventive Services Task Force. Evidence Review Update No. 74: AHRQ Publication No. 10-05142-EF-1; Rockville, MD2009.Agency for Healthcare Research and Quality

  • 20. Oeffinger K.C., Fontham E.T., Etzioni R., et. al.: Breast cancer screening for women at average risk: 2015 guideline update from the American Cancer Society. JAMA 2015; 314: pp. 1599-1614.

  • 21. Monticciolo D.L., Newell M.S., Hendrick R.E., et. al.: Breast cancer screening for average-risk women: recommendations from the ACR commission on breast imaging. J Am Coll Radiol 2017; 14: pp. 1137-1143.

  • 22. U.S. Food & Drug Administration : Mammography Quality Standards Act (MQSA). Updated February 5, 2015; Available at: https://www.fda.gov/Radiation-EmittingProducts/MammographyQualityStandardsActandProgram/Regulations/ucm110823.htm

  • 23. U.S. Food & Drug Administration : Search for a certified facility. Updated September 9, 2014; Available at: https://www.fda.gov/radiation-emittingproducts/mammographyqualitystandardsactandprogram/consumerinformation/ucm113962.htm

  • 24. UDS Mapper : ZIP code to ZCTA crosswalk. Available at: https://udsmapper.org/zcta-crosswalk.cfm?

  • 25. Unites States Census Bureau : Download 2010 ZIP Code Tabulation Area (ZCTA) relationship files. Available at: https://www.census.gov/geo/maps-data/data/zcta_rel_download.html

  • 26. Centers for Medicare & Medicaid Services : Physician and other supplier data CY 2015. Updated June 15, 2017; Available at: https://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/Medicare-Provider-Charge-Data/Physician-and-Other-Supplier2015.html

  • 27. Rosenkrantz A.B., Wang W., Hughes D.R., et. al.: Academic radiologist subspecialty identification using a novel claims-based classification system. AJR Am J Roentgenol 2017; pp. 1-7.

  • 28. Rosenkrantz A.B., Wang W., Bodapati S., et. al.: Private practice radiologist Subspecialty classification using Medicare claims. J Am Coll Radiol 2017; 14: pp. 1419-1425.

  • 29. Centers for Medicare & Medicaid Services : Medicare geographic variation. Public use file. Modified April 11, 2017; Available at: https://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/Medicare-Geographic-Variation/GV_PUF.html

  • 30. United States Department of Agriculture : Rural-urban commuting area codes. Updated October 12, 2016; Available at: https://www.ers.usda.gov/data-products/rural-urban-commuting-area-codes/

  • 31. County Health Rankings : Rankings data. Available at: http://www.countyhealthrankings.org/rankings/data

  • 32. McLafferty S., Grady S.: Prenatal care need and access: a GIS analysis. J Med Syst 2004; 28: pp. 321-333.

  • 33. Polsky D., Armstrong K.A., Randall T.C., et. al.: Variation in chemotherapy utilization in ovarian cancer: the relative contribution of geography. Health Serv Res 2006; 41: pp. 2201-2218.

  • 34. Punglia R.S., Weeks J.C., Neville B.A., et. al.: Effect of distance to radiation treatment facility on use of radiation therapy after mastectomy in elderly women. Int J Radiat Oncol Biol Phys 2006; 66: pp. 56-63.

  • 35. Keynes J.M.: The general theory of employment, interest, and money.1936.Harcourt, Brace, and CompanyNew Yorkpp. 1956.

  • 36. Alford-Teaster J., Lange J.M., Hubbard R.A., et. al.: Is the closest facility the one actually used? An assessment of travel time estimation based on mammography facilities. Int J Health Geogr 2016; 15: pp. 8.

  • 37. Wilkinson J.E., Lauer E., Freund K.M., et. al.: Determinants of mammography in women with intellectual disabilities. J Am Board Fam Med 2011; 24: pp. 693-703.

  • 38. O’Mahony N., McCarthy E., McDermott R., et. al.: Who’s the doctor? Patients’ perceptions of the role of the breast radiologist: a lesson for all radiologists. Br J Radiol 2012; 85: pp. e1184-e1189.

  • 39. Natesan R., Santiago L., Kalambo M., et. al.: The impact of patient demographics on the selection of breast imaging centers. AJR Am J Roentgenol 2017; pp. W1-W10.

  • 40. Weldon C.B., Friedewald S.M., Kulkarni S.A., et. al.: Radiology as the point of cancer patient and care team engagement: applying the 4R model at a patient’s breast cancer care initiation. J Am Coll Radiol 2016; 13: pp. 1579-1589.

  • 41. Qin X., Tangka F.K., Guy G.P., et. al.: Mammography rates after the 2009 revision to the United States Preventive Services Task Force breast cancer screening recommendation. Cancer Causes Control 2017; 28: pp. 41-48.

  • 42. Wright B.J., Conlin A.K., Allen H.L., et. al.: What does Medicaid expansion mean for cancer screening and prevention? Results from a randomized trial on the impacts of acquiring Medicaid coverage. Cancer 2016; 122: pp. 791-797.

  • 43. Allen S.S., Pruthi S.: The mammography controversy: when should you screen?. J Fam Pract 2011; 60: pp. 524-531.

  • 44. Young Lin L.L., Rosenkrantz A.B.: The U.S. online news coverage of mammography based on a Google news search. Acad Radiol 2017; 24: pp. 1612-1615.

  • 45. Rosenkrantz A.B., Hughes D.R., Duszak R.: State variation in medical imaging: despite great variation, the Medicare spending decline continues. AJR Am J Roentgenol 2015; 205: pp. 817-821.

  • 46. Jiang M., Hughes D.R., Appleton C.M., et. al.: Recent trends in adherence to continuous screening for breast cancer among Medicare beneficiaries. Prev Med 2015; 73: pp. 47-52.

This post is licensed under CC BY 4.0 by the author.